How to Buy Tg Therapeutics Stock
Tg Therapeutics Inc
TG Therapeutics, Inc. , a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
Tg Therapeutics stock last closed at $30.76, down 1.98% from the previous day, and has decreased 8.59% in one year. It has overperformed other stocks in the Biotechnology industry by 0.38 percentage points. Tg Therapeutics stock is currently +21.68% from its 52-week low of $25.28, and -33.82% from its 52-week high of $46.48.
At the moment, there are 158.76M shares of TGTX outstanding. The market value of TGTX is $4.88B. In the past 24 hours, 1.13M TGTX shares were traded.
How to Buy Tg Therapeutics Stock
Not sure how to invest in Tg Therapeutics stock? Here's how.
- Decide where to buy Tg Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you choose where to buy Tg Therapeutics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Select your method of payment and add your information.
- Research Tg Therapeutics stock: The Tg Therapeutics ticker symbol is TGTX. Is Tg Therapeutics stock a good investment? Should you buy shares of TGTX? How do TGTX's underlying business fundamentals look? Do top analysts think Tg Therapeutics is a good buy? Why has TGTX's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if TGTX is a good stock to buy).
- Execute your TGTX trade: Decide if you will purchase TGTX shares at the current market price or use a limit order to buy TGTX stock at a given price.
- Get key alerts regarding your investment in TGTX: Create a watchlist to watch your position in Tg Therapeutics shares.
Step 1: Decide where to buy Tg Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy TGTX stock.
Our preferred brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal details so you are able to buy TGTX today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create a new trading account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have opened your account on the best stock app for beginners, you can securely and quickly fund your account:
Watch this video walkthrough if you need help depositing funds into your brokerage account.
Step 4: Research Tg Therapeutics stock
After you have decided on the best place to buy Tg Therapeutics stock, it's absolutely critical to research their stock before you buy, so you truly comprehend the risk and upside.
Tg Therapeutics shares at a glance
Tg Therapeutics Due Diligence Checks
WallStreetZen was created to help part-time investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on TGTX's stock page.
What is the fair value of TGTX stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge TGTX's true value.
Using relative valuations metrics:
- TGTX may be undervalued based on its P/E ratio of 10.02x, relative to Biotechnology industry P/E ratio of 186.51x
- TGTX could be overvalued based on its P/B ratio of 8.04x, relative to Biotechnology industry P/B ratio of 5.29x
You can access more valuation analysis on TGTX's stock here.
Is TGTX a healthy company?
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the TGTX balance sheet.
- There are more short-term assets than long-term liabilities on the TGTX balance sheet.
- TGTX has $132.91M in cash and short term investments. This is enough to cover its annual cash burn of $70.24M.
- TGTX has cash burn of 70241000. It has sufficient cash and short-term investments to cover this for at least one year.
- TGTX profit margin has gone up from -5.4% to 84.1% in the past year.
Negative Health Checks:
- Total TGTX debt is higher than 5 years ago, relative to shareholder equity.
- TGTX has a relatively high debt to equity ratio of 0.69.
Is it a good time to buy TGTX stock, according to analysts?
Out of 3 Equities analysts who give forecasts on TGTX, the consensus analyst rating on TGTX is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Tg Therapeutics stock forecast page.
TGTX Technical Indicators
TGTX Growth Numbers
Last year, TGTX revenue was $531.90M. During the last 5 year, TGTX's revenue has grown by 411.44% per year. This was faster than the Biotechnology industry average of 44.12%.
You can research TGTX's earnings and revenue performance here.
Latest Insiders Trades at TGTX
In the last 12 months, insiders at TGTX have sold more shares than they have bought.
Yann Echelard, Director of TGTX, was the latest TGTX insider to sell. They sold $162,850.00 worth of TGTX shares on Nov 24, 2025.
Learn more about who owns TGTX stock here.
Does TGTX stock generate passive income?
No, Tg Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about TGTX
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your TGTX trade
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually sufficient. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.
Hit the Open button and your broker will place the order.
If you want additional help with investing in stocks on eToro, click the how to video below:
Step 6: Get key alerts regarding your investment in TGTX
Now that you own some shares in TGTX, you'll want to stay up-to-date on your investment.
Start a watchlist to keep tabs on your TGTX stock.
TGTX Feed
How to Buy Stock in Tg Therapeutics
To summarize, here are the 6 steps to buy stock in Tg Therapeutics:
- Decide where to buy Tg Therapeutics stock
- Open your brokerage account
- Deposit money your brokerage account
- Research Tg Therapeutics stock
- Execute your TGTX trade
- Get key alerts regarding your investment in TGTX
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to track your new investment in Tg Therapeutics, create your watchlist below.
More Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.